212 related articles for article (PubMed ID: 33712875)
1. Impact of resection margin status on survival in advanced N stage pancreatic cancer - a multi-institutional analysis.
Teske C; Stimpel R; Distler M; Merkel S; Grützmann R; Bolm L; Wellner U; Keck T; Aust DE; Weitz J; Welsch T
Langenbecks Arch Surg; 2021 Aug; 406(5):1481-1489. PubMed ID: 33712875
[TBL] [Abstract][Full Text] [Related]
2. Predictive factors for long-term survival after surgery for pancreatic ductal adenocarcinoma: Making a case for standardized reporting of the resection margin using certified cancer center data.
Weyhe D; Obonyo D; Uslar VN; Stricker I; Tannapfel A
PLoS One; 2021; 16(3):e0248633. PubMed ID: 33735191
[TBL] [Abstract][Full Text] [Related]
3. Distal Bile Duct Cancer: Radical (R0 > 1 mm) Resection Achieves Favorable Survival.
Tjaden C; Hinz U; Klaiber U; Heger U; Springfeld C; Goeppert B; Schmidt T; Mehrabi A; Strobel O; Berchtold C; Schneider M; Diener M; Neoptolemos JP; Hackert T; Büchler MW
Ann Surg; 2023 Jan; 277(1):e112-e118. PubMed ID: 34171863
[TBL] [Abstract][Full Text] [Related]
4. Microscopic resection margin status in pancreatic ductal adenocarcinoma - A nationwide analysis.
Daamen LA; van Goor IWJM; Schouten TJ; Dorland G; van Roessel SR; Besselink MG; Bonsing BA; Bosscha K; Brosens LAA; Busch OR; van Dam RM; Fariña Sarasqueta A; Festen S; Groot Koerkamp B; van der Harst E; de Hingh IHJT; Intven MPW; Kazemier G; de Meijer VE; Nieuwenhuijs VB; Raicu GM; Roos D; Schreinemakers JMJ; Stommel MWJ; van Velthuysen MF; Verheij J; Verkooijen HM; van Santvoort HC; Molenaar IQ;
Eur J Surg Oncol; 2021 Mar; 47(3 Pt B):708-716. PubMed ID: 33323293
[TBL] [Abstract][Full Text] [Related]
5. Impact of resection margin status on recurrence and survival in pancreatic cancer surgery.
Tummers WS; Groen JV; Sibinga Mulder BG; Farina-Sarasqueta A; Morreau J; Putter H; van de Velde CJ; Vahrmeijer AL; Bonsing BA; Mieog JS; Swijnenburg RJ
Br J Surg; 2019 Jul; 106(8):1055-1065. PubMed ID: 30883699
[TBL] [Abstract][Full Text] [Related]
6. R0 Versus R1 Resection Matters after Pancreaticoduodenectomy, and Less after Distal or Total Pancreatectomy for Pancreatic Cancer.
Demir IE; Jäger C; Schlitter AM; Konukiewitz B; Stecher L; Schorn S; Tieftrunk E; Scheufele F; Calavrezos L; Schirren R; Esposito I; Weichert W; Friess H; Ceyhan GO
Ann Surg; 2018 Dec; 268(6):1058-1068. PubMed ID: 28692477
[TBL] [Abstract][Full Text] [Related]
7. Intraoperative Pancreatic Neck Margin Assessment During Pancreaticoduodenectomy for Pancreatic Adenocarcinoma in the Era of Neoadjuvant Therapy: A Multi-institutional Analysis from the Central Pancreatic Consortium.
Kelly KN; Macedo FI; Seaton M; Wilson G; Hammill C; Martin RC; Maduekwe UN; Kim HJ; Maithel SK; Abbott DE; Ahmad SA; Kooby DA; Merchant NB; Datta J
Ann Surg Oncol; 2022 Sep; 29(9):6004-6012. PubMed ID: 35511392
[TBL] [Abstract][Full Text] [Related]
8. Prospective assessment of resection margin status following pancreaticoduodenectomy for pancreatic ductal adenocarcinoma after standardisation of margin definitions.
Pine JK; Haugk B; Robinson SM; Darne A; Wilson C; Sen G; French JJ; White SA; Manas DM; Charnley RM
Pancreatology; 2020 Apr; 20(3):537-544. PubMed ID: 31996296
[TBL] [Abstract][Full Text] [Related]
9. Prognostic value of the circumferential resection margin and its definitions in esophageal cancer patients after neoadjuvant chemoradiotherapy.
Depypere L; Moons J; Lerut T; De Hertogh G; Peters C; Sagaert X; Coosemans W; Van Veer H; Nafteux P
Dis Esophagus; 2018 Feb; 31(2):. PubMed ID: 29036407
[TBL] [Abstract][Full Text] [Related]
10. Clinical impacts of resection margin status and clinicopathologic parameters on pancreatic ductal adenocarcinoma.
Jamiyan T; Shiraki T; Kurata Y; Ichinose M; Kubota K; Imai Y
World J Surg Oncol; 2020 Jun; 18(1):137. PubMed ID: 32571348
[TBL] [Abstract][Full Text] [Related]
11. Validation of at least 1 mm as cut-off for resection margins for pancreatic adenocarcinoma of the body and tail.
Hank T; Hinz U; Tarantino I; Kaiser J; Niesen W; Bergmann F; Hackert T; Büchler MW; Strobel O
Br J Surg; 2018 Aug; 105(9):1171-1181. PubMed ID: 29738626
[TBL] [Abstract][Full Text] [Related]
12. The Impact of Positive Resection Margins on Survival and Recurrence Following Resection and Adjuvant Chemotherapy for Pancreatic Ductal Adenocarcinoma.
Ghaneh P; Kleeff J; Halloran CM; Raraty M; Jackson R; Melling J; Jones O; Palmer DH; Cox TF; Smith CJ; O'Reilly DA; Izbicki JR; Scarfe AG; Valle JW; McDonald AC; Carter R; Tebbutt NC; Goldstein D; Padbury R; Shannon J; Dervenis C; Glimelius B; Deakin M; Anthoney A; Lerch MM; Mayerle J; Oláh A; Rawcliffe CL; Campbell F; Strobel O; Büchler MW; Neoptolemos JP;
Ann Surg; 2019 Mar; 269(3):520-529. PubMed ID: 29068800
[TBL] [Abstract][Full Text] [Related]
13. Prognostic Factors of Survival After Neoadjuvant Treatment and Resection for Initially Unresectable Pancreatic Cancer.
Klaiber U; Schnaidt ES; Hinz U; Gaida MM; Heger U; Hank T; Strobel O; Neoptolemos JP; Mihaljevic AL; Büchler MW; Hackert T
Ann Surg; 2021 Jan; 273(1):154-162. PubMed ID: 30921051
[TBL] [Abstract][Full Text] [Related]
14. Pancreatic ductal adenocarcinoma: is there a survival difference for R1 resections versus locally advanced unresectable tumors? What is a "true" R0 resection?
Konstantinidis IT; Warshaw AL; Allen JN; Blaszkowsky LS; Castillo CF; Deshpande V; Hong TS; Kwak EL; Lauwers GY; Ryan DP; Wargo JA; Lillemoe KD; Ferrone CR
Ann Surg; 2013 Apr; 257(4):731-6. PubMed ID: 22968073
[TBL] [Abstract][Full Text] [Related]
15. Microscopically positive (R1) resections do not affect survival in pancreatic head cancer.
Mois E; Graur F; Al-Hajjar N; Zaharie F; Bartos A; Bodea R; Zaharie T; Rusu I; Iancu C
Ann Ital Chir; 2017; 88():491-496. PubMed ID: 29339587
[TBL] [Abstract][Full Text] [Related]
16. Prognostic Value of Resection Margin Involvement After Pancreaticoduodenectomy for Ductal Adenocarcinoma: Updates From a French Prospective Multicenter Study.
Delpero JR; Jeune F; Bachellier P; Regenet N; Le Treut YP; Paye F; Carrere N; Sauvanet A; Adham M; Autret A; Poizat F; Turrini O; Boher JM
Ann Surg; 2017 Nov; 266(5):787-796. PubMed ID: 28953554
[TBL] [Abstract][Full Text] [Related]
17. Contemporary Reappraisal of Intraoperative Neck Margin Assessment During Pancreaticoduodenectomy for Pancreatic Ductal Adenocarcinoma: A Review.
Datta J; Willobee BA; Ryon EL; Shah MM; Drebin JA; Kooby DA; Merchant NB
JAMA Surg; 2021 May; 156(5):489-495. PubMed ID: 33533898
[TBL] [Abstract][Full Text] [Related]
18. Mesopancreatic excision for pancreatic ductal adenocarcinoma improves local disease control and survival.
Safi SA; Haeberle L; Fluegen G; Lehwald-Tywuschik N; Krieg A; Keitel V; Luedde T; Esposito I; Rehders A; Knoefel WT
Pancreatology; 2021 Jun; 21(4):787-795. PubMed ID: 33775563
[TBL] [Abstract][Full Text] [Related]
19. Impact of resection margin status on survival after operation for pancreatic head cancer with extrapancreatic nerve plexus invasion.
Konishi T; Takano S; Furukawa K; Takayashiki T; Kuboki S; Suzuki D; Sakai N; Hosokawa I; Mishima T; Ohtsuka M
J Surg Oncol; 2022 Nov; 126(6):1038-1047. PubMed ID: 35796724
[TBL] [Abstract][Full Text] [Related]
20. Validation of the American Joint Committee on Cancer 8th edition staging system for the pancreatic ductal adenocarcinoma.
Shin DW; Lee JC; Kim J; Woo SM; Lee WJ; Han SS; Park SJ; Choi KS; Cha HS; Yoon YS; Han HS; Hong EK; Hwang JH
Eur J Surg Oncol; 2019 Nov; 45(11):2159-2165. PubMed ID: 31202572
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
